Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ramipril Tablets

Approval Number

国药准字HJ20140440

CompanySanofi-Aventis Deutschland Gmbh

Registration Date

December 31, 2020

Previous Approval Numbers

H20140440

Drug Information

Generic Name

雷米普利片

Trade Name

瑞泰

Brand Name

瑞泰

Dosage Form

片剂

Strength

5mg

Drug Type

化学药品

Registration Date

December 31, 2020

Expiry Date

December 30, 2025

Company Information

Applicant Company

Company NameSanofi-Aventis Deutschland Gmbh

Company Address

Brüningstrasse 50 D-65926 Frankfurt(Main),Germany

Manufacturing Company

Company NameSANOFI SRL

Company Address

Strada Statale 17 KM 22 67019 Scoppito (L'Aquila), Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

雷米普利片 - NMPA 批准文号 | MedPath